Skip to main content
Premium Trial:

Request an Annual Quote

David Glover, Patrick Round, Diane Mellett, Mark Skaletsky, Jeffrey Allard

Premium

Cambridge Antibody Technology announced last week the retirement of chief medical officer David Glover from the company and the board after the company’s annual general meeting on Feb. 4. Following Glover’s retirement, Patrick Round, vice president for development at CAT, will join the company’s executive group which has responsibility for the operational management of CAT.

In addition, Diane Mellett, general counsel and company secretary at CAT, will join CAT’s board of directors following the Feb. 4 meeting.


Cambridge, UK-based antibody therapeutics company Domantis announced this week the appointment of Mark Skaletsky as non-executive chairman of the Domantis board of directors. Skaletsky is currently CEO of Trine Pharamaceuticals, a Massachusetts-based drug development company focused on renal, gastrointestinal and metabolic diseases. Skaletsky also serves on the boards of several other companies, including Alkermes and Immunogen. He is a member and former chairman of the board of the Biotechnology Industry Organization, Domantis said.


Jeffrey Allard has become vice president and chief scientific officer of Fujirebio Diagnostics, the Mavern, Pa.-based company said last week. He comes to FDI from Immunicon, where he was vice president of clinical research and development. Allard holds a PhD in biochemistry from Dartmouth College, an MS in immunology from Idaho State University, and a BS in pre-veterinary medicine from the University of New Hampshire.

 

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.